Urinary Tract Infections, Known Unknowns and Groupthink

BACKGROUND: Paediatric urinary tract infections (UTIs) place a major burden on healthcare systems. Urological management has traditionally focused heavily on diagnosing and surgically treating vesicoureteric reflux (VUR). However, VUR is absent in 70% of children presenting with a UTI. This review examines clinical gaps, treatment efficacy and systemic delays in updating clinical practices. METHODS: The paper synthesises historical definitions of bacteriuria, recent clinical trials (PRIVENT, RIVUR and PREDICT), data from the Cochrane review and a 10-year epidemiological dataset comprising 152 286 UTI presentations from New South Wales, Australia. RESULTS: Pooled Cochrane data show that low-dose antibiotic prophylaxis makes little or no difference to the risk of repeat symptomatic or febrile UTI. Surgical intervention benefits only severe cases (Grades 4 and 5) presenting with distal ureteric dilatation greater than 7 mm. For infant males, circumcision reduces UTI risk 10-fold. Epidemiological data show that male and female UTI incidence peaks during infancy and declines rapidly after 12 months, making uncontrolled cohort studies in infants misleadingly positive. Despite poor evidence for operative correction of VUR, 798 surgical papers were published between 2015 and 2025. CONCLUSION: Few effective treatments exist to prevent paediatric UTIs. Targeted circumcision in infant males with ureteric dilatation provides a reasonable number needed to treat. Surgical intervention and routine antibiotic prophylaxis yield minimal clinical benefit.